- The role of the immune system and the biomarker CD3+CD4+CD45RA-CD62L-in the pathophysiology of migraine2020 | Lékařská fakulta v Hradci Králové
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | Ústřední knihovna, 1. lékařská fakulta
- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu